Clinical trial
A Comparison of The Effectiveness of Tegoprazan and Lansoprazole in Achieving Cure Rates in Patients With Bleeding Peptic Ulcers: A Double-Blind Randomized Trial
NCT06894992 is registered in ClinicalTrials.gov with Mario Steffanus as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Comparison of The Effectiveness of Tegoprazan and Lansoprazole in Achieving Cure Rates in Patients With Bleeding Peptic Ulcers: A Double-Blind Randomized Trial
- Lead sponsor
- Mario Steffanus
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- May 1, 2025
- Completion date
- December 31, 2025
- Enrollment
- 162 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
peptic ulcer bleeding